Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Askling

Showing results (1-10 of 345) with videos related to

Pageof 35
Sort By:
Current Rheumatology Reports|October 5, 2007
Malignancy and rheumatoid arthritisJohan Askling
Rheumatology (Oxford, England)|May 7, 2019
Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: replyThomas Frisell, Johan Askling
Annals of the Rheumatic Diseases|March 5, 2011
Influence of biological agents on cardiovascular disease in rheumatoid arthritisJohan Askling, Will Dixon
Current Opinion in Rheumatology|March 20, 2008
The safety of anti-tumour necrosis factor therapy in rheumatoid arthritisJohan Askling, Will Dixon
Annals of the Rheumatic Diseases|February 2, 2021
Response to: 'Correspondence on 'Risk of venous thromboembolism in rheumatoid arthritis and its association with disease activity: a nationwide cohort study from Sweden'' by Zervou <i>et al</i>Viktor Molander, Johan Askling
Annals of the Rheumatic Diseases|March 19, 2014
Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et alMartin Neovius, Johan Askling
Current Opinion in Rheumatology|April 5, 2008
Malignancy and biologic therapy in rheumatoid arthritisJohan Askling, Tim Bongartz
Rheumatology (Oxford, England)|March 7, 2019
Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: replyThomas Frisell, Johan Askling
Annals of the Rheumatic Diseases|June 21, 2015
Does a family history of RA influence the clinical presentation and treatment response in RA?Thomas Frisell, Saedis Saevarsdottir, Johan Askling
Nature Reviews. Rheumatology|April 22, 2016
Family history of rheumatoid arthritis: an old concept with new developmentsThomas Frisell, Saedis Saevarsdottir, Johan Askling
Pageof 35

Showing results (1-10 of 345) with videos related to

Sort By:
Pageof 35
Current Rheumatology Reports|October 5, 2007
Malignancy and rheumatoid arthritisJohan Askling
Rheumatology (Oxford, England)|May 7, 2019
Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: replyThomas Frisell, Johan Askling
Annals of the Rheumatic Diseases|March 5, 2011
Influence of biological agents on cardiovascular disease in rheumatoid arthritisJohan Askling, Will Dixon
Current Opinion in Rheumatology|March 20, 2008
The safety of anti-tumour necrosis factor therapy in rheumatoid arthritisJohan Askling, Will Dixon
Annals of the Rheumatic Diseases|February 2, 2021
Response to: 'Correspondence on 'Risk of venous thromboembolism in rheumatoid arthritis and its association with disease activity: a nationwide cohort study from Sweden'' by Zervou <i>et al</i>Viktor Molander, Johan Askling
Annals of the Rheumatic Diseases|March 19, 2014
Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et alMartin Neovius, Johan Askling
Current Opinion in Rheumatology|April 5, 2008
Malignancy and biologic therapy in rheumatoid arthritisJohan Askling, Tim Bongartz
Rheumatology (Oxford, England)|March 7, 2019
Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: replyThomas Frisell, Johan Askling
Annals of the Rheumatic Diseases|June 21, 2015
Does a family history of RA influence the clinical presentation and treatment response in RA?Thomas Frisell, Saedis Saevarsdottir, Johan Askling
Nature Reviews. Rheumatology|April 22, 2016
Family history of rheumatoid arthritis: an old concept with new developmentsThomas Frisell, Saedis Saevarsdottir, Johan Askling
Pageof 35